Desq Long
Sign in
SEC FORM 4
$0.00

NewAmsterdam Pharma Co N.V. (NAMS)

Acquisition (code A) of 3,200 shares at $0 per share.

Reporting Person Gunning Robert William · Officer Title Vice President, Controller · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-381953 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "NewAmsterdam Pharma Co N.V. (NAMS)." Disclosed 2026-09-03. https://desqlong.com/cards/0001193125-26-381953-1 (retrieved 2026-09-26).